Stock Scorecard



Stock Summary for LifeMD Inc (LFMD) - $6.46 as of 8/29/2025 3:35:17 PM EST

Total Score

9 out of 30

Safety Score

34 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LFMD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LFMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LFMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LFMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LFMD (34 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for LFMD

LFMD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against LifeMD, Inc. - LifeMD ( NASDAQ:LFMD ) 8/29/2025 6:52:00 PM
DEADLINE ALERT for PUBM, SNAP, NUTX, and LFMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - LifeMD ( NASDAQ:LFMD ) , Nutex Health ( NASDAQ:NUTX ) 8/29/2025 4:14:00 PM
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - LifeMD ( NASDAQ:LFMD ) 8/29/2025 4:00:00 PM
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - LifeMD ( NASDAQ:LFMD ) 8/28/2025 11:46:00 PM
LifeMD, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit - LifeMD ( NASDAQ:LFMD ) 8/28/2025 9:04:00 PM
LIFEMD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against LifeMD, Inc. and Encourages Investors to Contact the Firm - LifeMD ( NASDAQ:LFMD ) 8/28/2025 8:20:00 PM
LifeMD to Participate in Three Investor Conferences During September - LifeMD ( NASDAQ:LFMDP ) , LifeMD ( NASDAQ:LFMD ) 8/28/2025 12:00:00 PM
LifeMD, Inc. ( LFMD ) Hit With Securities Class Action After Shares Crash 44% On Q2 2025 Earnings Surprise, Problems With Obesity Care and RexMD -- Hagens Berman - LifeMD ( NASDAQ:LFMD ) 8/27/2025 11:57:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD - LifeMD ( NASDAQ:LFMD ) 8/21/2025 5:55:00 PM
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals 8/19/2025 2:01:00 PM

Financial Details for LFMD

Company Overview

Ticker LFMD
Company Name LifeMD Inc
Country USA
Description LifeMD, Inc. is a direct-to-patient telehealth company connecting consumers with healthcare professionals for care in various indications, including concierge care, men's sexual health, dermatology, and others in the United States. . The company is headquartered in New York, New York.
Sector Name LIFE SCIENCES
Industry Name MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 6.46
Price 4 Years Ago 3.87
Last Day Price Updated 8/29/2025 3:35:17 PM EST
Last Day Volume 1,051,218
Average Daily Volume 2,195,113
52-Week High 15.84
52-Week Low 3.99
Last Price to 52 Week Low 61.90%

Valuation Measures

Trailing PE N/A
Industry PE 18.50
Sector PE 60.89
5-Year Average PE -91.81
Free Cash Flow Ratio 8.50
Industry Free Cash Flow Ratio 38.73
Sector Free Cash Flow Ratio 30.76
Current Ratio Most Recent Quarter 0.77
Total Cash Per Share 0.76
Book Value Per Share Most Recent Quarter -0.04
Price to Book Ratio 107.72
Industry Price to Book Ratio 1.29
Sector Price to Book Ratio 26.74
Price to Sales Ratio Twelve Trailing Months 1.25
Industry Price to Sales Ratio Twelve Trailing Months 2.25
Sector Price to Sales Ratio Twelve Trailing Months 13.32
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 47,417,400
Market Capitalization 306,316,404
Institutional Ownership 53.70%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 8.32%
Reported EPS 12 Trailing Months -0.20
Reported EPS Past Year -0.03
Reported EPS Prior Year -0.31
Net Income Twelve Trailing Months -6,704,370
Net Income Past Year -18,882,000
Net Income Prior Year -20,595,992
Quarterly Revenue Growth YOY 22.80%
5-Year Revenue Growth 76.32%
Operating Margin Twelve Trailing Months -1.46%

Balance Sheet

Total Cash Most Recent Quarter 36,228,305
Total Cash Past Year 35,004,924
Total Cash Prior Year 33,146,725
Net Cash Position Most Recent Quarter 32,710,988
Net Cash Position Past Year 25,119,867
Long Term Debt Past Year 9,885,057
Long Term Debt Prior Year 17,927,727
Total Debt Most Recent Quarter 3,517,317
Equity to Debt Ratio Past Year -1.25
Equity to Debt Ratio Most Recent Quarter -1.03
Total Stockholder Equity Past Year -5,485,501
Total Stockholder Equity Prior Year 3,505,372
Total Stockholder Equity Most Recent Quarter -1,782,554

Free Cash Flow

Free Cash Flow Twelve Trailing Months 7,530,401
Free Cash Flow Per Share Twelve Trailing Months 0.16
Free Cash Flow Past Year 5,976,872
Free Cash Flow Prior Year 86,948

Options

Put/Call Ratio 0.15
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.09
MACD Signal -1.21
20-Day Bollinger Lower Band 4.13
20-Day Bollinger Middle Band 9.81
20-Day Bollinger Upper Band 15.49
Beta 1.72
RSI 35.57
50-Day SMA 7.17
150-Day SMA 5.76
200-Day SMA 5.09

System

Modified 8/30/2025 3:39:05 AM EST